{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:32:44Z","timestamp":1790695964088,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.clinbiochem.2012.09.007","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T04:48:43Z","timestamp":1348030123000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["The paradox of ApoA5 modulation of triglycerides: Evidence from clinical and basic research"],"prefix":"10.1016","volume":"46","author":[{"given":"Mahdi","family":"Garelnabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenton","family":"Lor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini","family":"Santanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0010","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M106888200","article-title":"Apolipoprotein A-V: a novel apolipoproein associated with an early phase liver regeneration","volume":"276","author":"van der Vliet","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0015","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1161\/01.ATV.0000193889.65915.f9","article-title":"Apolipoprotein AV low concentration, high impact","volume":"25","author":"Rensen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0020","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0006-291X(02)00808-2","article-title":"Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice","volume":"295","author":"van der Vliet","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1373\/clinchem.2004.040824","article-title":"The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins","volume":"51","author":"O'Brien","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0030","doi-asserted-by":"crossref","first-page":"34438","DOI":"10.1074\/jbc.M303784200","article-title":"Structure and interfacial properties of human apolipoprotein A-V","volume":"278","author":"Weinberg","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0035","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.ATV.0000130463.68272.1d","article-title":"Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice","volume":"24","author":"Baroukh","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0040","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1074\/jbc.M411412200","article-title":"Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase","volume":"280","author":"Merkel","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0045","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","article-title":"ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis","volume":"279","author":"Schaap","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.clinbiochem.2012.09.007_bb0050","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/MCB.25.4.1537-1548.2005","article-title":"Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor","volume":"25","author":"Nowak","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.clinbiochem.2012.09.007_bb0055","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/bi7000533","article-title":"Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family","volume":"46","author":"Nilsson","year":"2007","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.09.007_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbalip.2010.02.004","article-title":"Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation","volume":"1801","author":"Shu","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.09.007_bb0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2004.04.018","article-title":"Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL","volume":"176","author":"Khovidhunkit","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2005.11.105","article-title":"Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans","volume":"20","author":"Becker","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1194\/jlr.M500343-JLR200","article-title":"Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks","volume":"47","author":"Hodoglugil","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0080","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1194\/jlr.M300251-JLR200","article-title":"The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore","volume":"44","author":"Lai","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0085","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1093\/hmg\/ddg255","article-title":"A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia","volume":"19","author":"Kao","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0090","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","article-title":"Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels","volume":"11","author":"Pennachio","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2350-10-111","article-title":"Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis","volume":"10","author":"Chen","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.trsl.2009.06.005","article-title":"Association between sequence variant of c.553 G>T in the apolipoprotein AS gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis","volume":"154","author":"Chien","year":"2009","journal-title":"Transl Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0105","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1194\/jlr.M500446-JLR200","article-title":"Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study","volume":"47","author":"Elosua","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0110","doi-asserted-by":"crossref","first-page":"28215","DOI":"10.1074\/jbc.M502144200","article-title":"Determination of the functionality of common APOA5 polymorphisms","author":"Talmud","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0115","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1194\/jlr.M400192-JLR200","article-title":"Influence of the APOAT locus on plasma triglyceride, lipoprotein subclasses, and CVD risks in the Framingham Heart Study","volume":"45","author":"Lai","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0120","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/clinchem\/48.9.1597","article-title":"Newly identified apolipoprotein AV predisposes to high plasma triglycerides in familial combined hyperlipidemia","volume":"48","author":"Ribalta","year":"2002","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.09.007_bb0125","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1194\/jlr.M200480-JLR200","article-title":"Genetic variants of a polymorphism in the human apoA-V gene: effect on plasma lipids","volume":"44","author":"Aouizerat","year":"2003","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.09.007_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2012.02.030","article-title":"Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol","volume":"222","author":"Shirts","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.09.007_bb0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.mol.0000217892.00618.54","article-title":"APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency","volume":"17","author":"Calandra","year":"2006","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"10.1016\/j.clinbiochem.2012.09.007_bb0140","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.ATV.0000186189.26141.12","article-title":"Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants","volume":"25","author":"Grosskopf","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.09.007_bb0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1373\/clinchem.2004.044826","article-title":"Apolipoprotein A5 and hypertriglyceridemia","volume":"51","author":"Charlton-Menys","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0021-9150(02)00252-6","article-title":"The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese","volume":"165","author":"Nabika","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0155","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00439-002-0825-0","article-title":"Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren","volume":"lll","author":"Endo","year":"2002","journal-title":"Hum Genet"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0160","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1194\/jlr.M700011-JLR200","article-title":"APOA5 variants and metabolic syndrome in Caucasians","volume":"48","author":"Grallert","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0165","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ejhg.2010.93","article-title":"A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese","volume":"18","author":"Jiang","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0170","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.atherosclerosis.2008.11.019","article-title":"Association of plasma apolipoprotein AV with lipid profiles in patients with acute coronary syndrome","volume":"204","author":"Huang","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0175","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.atherosclerosis.2008.12.035","article-title":"Association of apolipoprotein AS concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men","volume":"205","author":"Hyun","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2005.05.031","article-title":"Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan","volume":"185","author":"Hsu","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2004.04.024","article-title":"APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease","volume":"176","author":"Lee","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2006.04.009","article-title":"The \u22121131T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-lll, but not with coronary artery disease: an angiographic study","volume":"191","author":"Martinelli","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.atherosclerosis.2010.11.011","article-title":"Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction","volume":"214","author":"De Caterina","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0200","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1194\/jlr.M500446-JLR200","article-title":"Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study","volume":"47","author":"Elosua","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cccn.2004.05.011","article-title":"Genetic analysis of APOAV polymorphisms (T-1131\/C, Serl9\/Trp and Vall53\/Met): no effect on plasma remnant particles concentrations","volume":"348","author":"Hubacek","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/ATVBAHA.109.188912","article-title":"Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis","volume":"30","author":"Laurila","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2009.08.013","article-title":"Associations of polymorphisms in the apolipoprotein A1\/C3\/A4\/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese","volume":"208","author":"Liu","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/2047-783X-16-2-79","article-title":"Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein AS gene","volume":"16","author":"Evans","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-230X-9-46","article-title":"Lipoprotein lipase activity and mass, apolipoprotein C-ll mass and polymorphisms of apolipoproteins E and AS in subjects with prior acute hypertriglyceridaemic pancreatitis","volume":"9","author":"Coca-Prieto","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0230","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1515\/CCLM.2007.257","article-title":"Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome","volume":"45","author":"Niculescu","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0235","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2009.11.103","article-title":"Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome","volume":"391","author":"Niculescu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1253\/circj.72.40","article-title":"Apolipoprotein AS IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians","volume":"72","author":"Kisfali","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0245","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2265.2010.03899.x","article-title":"Association of a genetic variant in the apolipoprotein AS gene with the metabolic syndrome in Chinese","volume":"74","author":"Ong","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0250","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/gtmb.2010.0256","article-title":"Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population","volume":"15","author":"Vasilopoulos","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0255","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.atherosclerosis.2009.12.004","article-title":"Decreased apolipoprotein A5 is implicated in insulin resistance-related hypertriglyceridemia in obesity","volume":"210","author":"Huang","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0260","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/oby.2010.10","article-title":"A triglyceride-raising APOA5 genetic variant is negatively associated with obesity and BMI in the Chinese population","volume":"18","author":"Wu","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0265","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.3109\/17477166.2010.490268","article-title":"Haplotype analysis of the apolipoprotein AS gene in obese pediatric patients","volume":"6","author":"Horvatovich","year":"2011","journal-title":"Int J Pediatr Obes"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0270","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11745-010-3426-z","article-title":"APOA1\/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort","volume":"45","author":"Chen","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0275","first-page":"6","article-title":"Correlation of metabolic syndrome clinical signs and genetic determinants at children with obese","volume":"7","author":"Shcherbakova","year":"2010","journal-title":"Eksp Klin Gastroenterol"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0280","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/oby.2009.216","article-title":"Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin","volume":"18","author":"Smith","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0285","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.atherosclerosis.2006.05.006","article-title":"Associations of the apolipoprotein A1\/C3\/A4\/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes","volume":"192","author":"Qi","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0290","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2010.03.014","article-title":"APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects","volume":"211","author":"Jang","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0295","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000165358","article-title":"Changes of plasma lipids during weight reduction in females depends on APOA5 variants","volume":"53","author":"Suchanek","year":"2008","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0300","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00109-006-0147-0","article-title":"APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study","volume":"85","author":"Corella","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0305","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3945\/jn.110.130344","article-title":"APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population","volume":"141","author":"Sanchez-Moreno","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2005.11.029","article-title":"A single nucleotide polymorphism of the apolipoprotein A-V gene \u22121131T>C modulates postprandial lipoprotein metabolism","volume":"189","author":"Moreno","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0315","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1210\/jc.2006-1802","article-title":"Two independent apolipoprotein AS haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population","volume":"92","author":"Moreno-Luna","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0320","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1399-0004.2005.00463.x","article-title":"A polymorphism in the apolipoprotein AS gene is associated with weight loss after short-term diet","volume":"68","author":"Aberle","year":"2005","journal-title":"Clin Genet"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0325","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.atherosclerosis.2005.01.034","article-title":"Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients","volume":"181","author":"Pruneta-Deloche","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0330","doi-asserted-by":"crossref","first-page":"555","DOI":"10.33549\/physiolres.931245","article-title":"Lipoprotein lipase activity determined in vivo is lower in carriers of apolipoprotein A-V gene variants 19W and \u22121131C","volume":"57","author":"Kovar","year":"2008","journal-title":"Physiol Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0335","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.atherosclerosis.2011.01.011","article-title":"Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status","volume":"215","author":"Feitosa","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0340","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.atherosclerosis.2011.08.015","article-title":"Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia","volume":"219","author":"Brautbar","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0345","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2009.02.024","article-title":"The \u22121131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study","volume":"206","author":"Cardona","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0350","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1373\/clinchem.2006.069583","article-title":"Protease inhibitor associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T\u2013>C gene variation","volume":"52","author":"Guardiola","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0355","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.atherosclerosis.2010.07.004","article-title":"The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study)","volume":"212","author":"Guardiola","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0360","first-page":"751","article-title":"Expression profiles of lipid metabolism related genes in liver of apoE(\u2212\/\u2212)\/LDLR(\u2212\/\u2212) mice","volume":"36","author":"Du Ha Yin","year":"2007","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0365","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCRESAHA.108.179861","article-title":"Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia","volume":"103","author":"Mansouri","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0370","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-006-0171-1","article-title":"Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats","volume":"49","author":"Dorfmeister","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0375","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1194\/jlr.M700281-JLR200","article-title":"Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice","volume":"49","author":"Nelbach","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0380","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.metabol.2008.11.018","article-title":"Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis","volume":"58","author":"Pamir","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.clinbiochem.2012.09.007_bb0385","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/ATVBAHA.110.210815","article-title":"Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav\u2212\/\u2212 mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1","volume":"30","author":"Shu","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.09.007_bb0390","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2005.02.151","article-title":"Identification of the human ApoAV gene as a novel RORalpha target gene","volume":"330","author":"Lind","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.09.007_bb0395","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.atherosclerosis.2007.12.026","article-title":"Dietary oxidized linoleic acid lowers triglycerides via APOA5\/APOClll dependent mechanisms","volume":"199","author":"Garelnabi","year":"2008","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.09.007_bb0400","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCRESAHA.108.179861","article-title":"Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia","volume":"103","author":"Mansouri","year":"2008","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.09.007_bb0405","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.atherosclerosis.2009.12.004","article-title":"Decreased apolipoprotein A5 is implicated in insulin resistance-related hypertriglyceridemia in obesity","volume":"210","author":"Huang","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.09.007_bb0410","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2010.09.084","article-title":"Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein","volume":"401","author":"Zhang","year":"2010","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012005371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012005371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:38:50Z","timestamp":1757864330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012005371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":82,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0009912012005371"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.007","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The paradox of ApoA5 modulation of triglycerides: Evidence from clinical and basic research","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}